Physician in the Loop: Pediatrics Transistor (https://transistor.fm) https://feeds.transistor.fm/physician-in-the-loop-pediatrics The week's innovation news in pediatrics for pediatricians, every Sunday in a few minutes: new technology, AI tools, devices, FDA decisions and new ways of delivering care. From the Specialties pages of Physician in the Loop, where every story links to its sources: physicianintheloop.org/specialties/pediatrics/. Read by AI voices. Nomad Medical Group, PLLC 49cc434b-5862-52f2-820a-5d4dda6d691d yes en Mon, 12 Oct 2026 10:18:24 -0600 Mon, 12 Oct 2026 10:19:17 -0600 https://physicianintheloop.org/specialties/pediatrics/ https://img.transistorcdn.com/Uw0MF--Qb5biHBgoQLYUGien4g6RjS27jmapAqLeq5o/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9iYmVi/OGVmOTJiMTY2NjU3/YTlhZWE3MTY1YzYz/MzM1Ny5qcGc.jpg Physician in the Loop: Pediatrics https://physicianintheloop.org/specialties/pediatrics/ episodic Nomad Medical The week's innovation news in pediatrics for pediatricians, every Sunday in a few minutes: new technology, AI tools, devices, FDA decisions and new ways of delivering care. From the Specialties pages of Physician in the Loop, where every story links to its sources: physicianintheloop.org/specialties/pediatrics/. Read by AI voices. The week's innovation news in pediatrics for pediatricians, every Sunday in a few minutes: new technology, AI tools, devices, FDA decisions and new ways of delivering care. pediatrics, pediatrics news, innovation, medicine, physicians, AI in medicine, weekly briefing Ryan Gillum No No Weekly Briefing for September 28 to October 4, 2026 1 1 Weekly Briefing for September 28 to October 4, 2026 full a9cc6573-f9bd-430b-a13d-6caea094e8b6 https://share.transistor.fm/s/c9f3aaa0 The Food and Drug Administration (FDA) on Oct. 1 approved the Autus Size-Adjustable Valve, the first heart valve designed to be expanded after surgery to keep pace with a child's growth. In JAMA, the PRESSURE trial found no significant difference in 30-day mortality and ventilation duration with a permissive pediatric intensive care blood pressure target, which cut norepinephrine-equivalent dose 37.5%. The Centers for Disease Control and Prevention (CDC) counted 3,887 measles cases this year as of Oct. 1, and the FDA approved the first treatment for MCT8 deficiency.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/pediatrics/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> The Food and Drug Administration (FDA) on Oct. 1 approved the Autus Size-Adjustable Valve, the first heart valve designed to be expanded after surgery to keep pace with a child's growth. In JAMA, the PRESSURE trial found no significant difference in 30-day mortality and ventilation duration with a permissive pediatric intensive care blood pressure target, which cut norepinephrine-equivalent dose 37.5%. The Centers for Disease Control and Prevention (CDC) counted 3,887 measles cases this year as of Oct. 1, and the FDA approved the first treatment for MCT8 deficiency.

Read this week's roundup and its sources: https://physicianintheloop.org/specialties/pediatrics/2026-09-28/

The voices on this episode are generated by AI, and so is the script, from the week's specialty roundup at Physician in the Loop. Every fact in the roundup links to its source.

]]> Mon, 05 Oct 2026 22:37:13 -0600 Nomad Medical Nomad Medical 286 FDA approves first heart valve designed to grow with children; PICU trial tests permissive blood pressure targets; U.S. measles cases reach 3,887 FDA approves first heart valve designed to grow with children; PICU trial tests permissive blood pressure targets; U.S. measles cases reach 3,887 Pediatrics,physicians,medical news,weekly briefing No